HB9054, titled the Earned Benefits Equality and Family Reunification Act, would direct the Secretary of Health and Human Services to create a 10-year Medicare demonstration program for international coverage. The program would let eligible Medicare beneficiaries use Medicare benefits to pay for covered items and services, premiums, and cost-sharing under the health systems of selected foreign countries. The bill is framed as a pilot project to test whether international coverage can improve care quality, lower government costs, and help beneficiaries reunite with family members abroad.
The Secretary would be required to design the program within one year of enactment, consult with stakeholders, and select at least 11 countries or political subdivisions, including Canada, Germany, India, Israel, Korea, the Philippines, Panama, Mexico, the Dominican Republic, and Ghana. Participation would be voluntary, and beneficiaries could leave the program at any time. The bill also preserves beneficiaries’ access to Medicare-covered services in the United States, sets a minimum enrollment cap of 150,000 participants, and allows Medicare Advantage organizations to help administer the program.
The bill would amend Title XVIII of the Social Security Act by adding a new section authorizing Medicare to make payments for care received abroad, subject to limits intended to keep total spending no higher than what Medicare would have paid for comparable care in the United States. It would also allow payments for premiums and cost-sharing, prohibit duplicate payment for the same month, require physician certification and fraud/waste/abuse training, and direct annual and final evaluations with recommendations to Congress on whether to expand the program. Funding would come from Medicare trust funds and administrative funds under the Center for Medicare and Medicaid Innovation authority.
The general sentiment reflected in the bill text is supportive and reform-oriented, emphasizing expanded access, family reunification, and potential cost savings rather than restriction. Because there were no committee transcripts or recorded votes provided, there is no documented floor or committee sentiment to compare against the bill’s stated goals. The structure of the bill suggests an experimental, data-driven approach intended to test feasibility before any broader policy change.
The main points of contention likely concern whether Medicare should finance care outside the United States, how to ensure quality and oversight in foreign systems, and whether the program could create administrative or fraud risks. The bill tries to address those concerns by limiting eligible countries, requiring quality standards, capping enrollment, mandating fraud training, and barring review of many program-design decisions. Potential critics may also question the use of Medicare trust funds for overseas coverage and the waiver of certain statutory and administrative requirements.
HB9054 would amend the Social Security Act to add a new Medicare demonstration authority for international coverage, creating a significant new exception to the usual domestic focus of Medicare benefits. It would affect Title XVIII, including Medicare Parts A, B, and potentially C and D administration, and would authorize the Secretary to waive other Medicare provisions as needed to run the pilot. The bill would also direct use of Medicare trust funds and Center for Medicare and Medicaid Innovation resources to finance and evaluate the program, while preserving beneficiaries’ existing U.S. Medicare access.
The bill’s tone is broadly favorable toward expanding Medicare flexibility for beneficiaries who live abroad or relocate internationally. Its findings and design emphasize improved care, lower costs, and family reunification, suggesting a positive policy intent. No votes or hearing transcripts were provided, so there is no recorded opposition or support from lawmakers to characterize beyond the bill’s own framing.
Likely areas of controversy include whether Medicare should pay for care in foreign health systems, whether the selected countries can meet U.S.-level quality expectations, and whether the program could be vulnerable to waste, fraud, abuse, or uneven administration. The bill anticipates these concerns by requiring stakeholder consultation, quality guidance, physician certification, fraud training, and spending limits tied to domestic Medicare costs. Another possible point of contention is the bill’s broad waiver and limited-review provisions, which reduce oversight and may concern critics who want stronger administrative or judicial checks.